Scientists spot genes that make some sarcomas less aggressive

September 20, 2016 by David Ruth, Rice University

Scientists at Rice and Duke universities have identified a set of genes they say make sarcoma cells less aggressive. They hope to turn the discovery into new therapeutic approaches to fight metastatic cancers.

The work by members of Rice's Center for Theoretical Biological Physics led by co-director and biophysicist Herbert Levine and scientists at Duke combined simulations and experiments to uncover genes that regulate how cells transition from epithelial (nonmobile) to mesenchymal (migrating)—or vice versa.

The work appears on the October cover of the American Society for Microbiology journal Molecular and Cellular Biology.

The epithelial-to-mesenchymal transition, known as EMT, is a characteristic of developmental processes but can be hijacked by cells that turn cancerous and metastatic. A previous study by Rice's theoretical group found that during EMT, some cells are in a hybrid state that has both epithelial and mesenchymal properties, including group migration.

The reverse, aka MET, is important to normal development but is also suspected of helping roving mesenchymal cancer cells use epithelial characteristics to settle in distant organs and initiate metastasis.

"We're interested in understanding the hierarchy of controls that cells use when they change from one phenotype to another," Levine said. "Most of the work here has been on , which start out as epithelial and then, as part of the metastatic process, pick up mesenchymal-like properties in order to move and evade detection.

"Here the opportunity was to look at the same process, but almost in reverse. Here we have a cell that's really mesenchymal, but it has picked up certain properties to be epithelial," he said. "We were interested in how symmetric these processes were. And the answer is there are some degrees of symmetry but there are some clear differences that seem to involve what I think of as the second layer of how regulation works."

Cells change their orientation from mesenchymal to epithelial or back depending on genetic signals or mutations, Levine said. "When a gene is expressed for a very long time—or not expressed for a very long time—that gets encoded at the structural level of DNA," he said. "So the DNA of genes that are used often are more accessible.

"We discovered these , which are really mesenchymal, have gone to this extra structural level of DNA organization where epithelial-like genes are more strongly constrained." That, he said, makes it much harder for hybrid cells to drop their epithelial traits.

Both EMT and MET exhibit what's called phenotypic plasticity, in this case the ability of a cell to change its type in response to changes in its environment. But in some types of sarcomas—malignant tumors that develop in soft tissue and bone – roving seem to acquire a greater share of the traits of stationary epithelial cells.

According to lead author Jason Somarelli of Duke Cancer Institute, "Patients whose sarcomas have more of these epithelial-like traits have better survival outcomes. They live longer than patients whose sarcomas do not exhibit this ."

The team found that in multiple sarcoma cell lines, the combined expression of the micro RNA-200 family and upregulation of an epithelial gene activator, GRHL2, led to downregulation of the ZEB1 protein, which makes cells lean more toward epithelial-like behavior and therefore less aggressive.

The initiative at Duke first caught the eye of Rice graduate student Mohit Kumar Jolly, who with Levine has published related works based on predictive computer simulations of biological systems. The ability of cells to become epithelial-mesenchymal hybrids was the topic of a 2015 study in which the Rice team discovered that tumors depend on these hybrids to hijack cell-signaling processes.

"We thought they were looking at the same players that we were, but they are connected differently in sarcomas as compared to carcinomas," Jolly said. "They had different results from what our initial model predicted, so we developed a new mathematical model to capture cellular plasticity in sarcomas."

The next challenge, Levine said, will be to understand the mechanism by which genes that encode the relevant proteins are made available in DNA's chromatin structure, a subject of ongoing study at Rice. "We want to understand how those factors either help or prevent cells from going through the phenotypic transitions we think are important for cancer metastasis," he said.

Explore further: Cancer cells coordinate to form roving clusters

More information: Jason A. Somarelli et al. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2, Molecular and Cellular Biology (2016). DOI: 10.1128/MCB.00373-16

Related Stories

Cancer cells coordinate to form roving clusters

May 19, 2016
Two-way communication between cancer cells appears to be key to their becoming motile, clustering and spreading through metastasis, according to Rice University scientists.

Breast cancer stem cells radicalize normal neighbors for purpose of metastasis

April 18, 2016
A University of Colorado Cancer Center study presented at the American Association for Cancer Research Annual Meeting 2016 shows that stem-like breast cancer cells secrete molecules that allow neighboring, otherwise anchored ...

Decoding the emergence of metastatic cancer stem cells

October 31, 2014
In the first study of its kind, Rice University researchers have mapped how information flows through the genetic circuits that cause cancer cells to become metastatic. The research reveals a common pattern in the decision-making ...

Researchers describe a new function of two molecules involved in metastasis

November 14, 2013
Researchers from IMIM (Hospital del Mar Medical Research Institute) lead by Dr. Sandra Peiró have described a new function for two key molecules involved in tumor progression. Transcription factor SNAIL1 and enzyme LOXL2 ...

Scientists use modelling to show the role of metabolism and signaling in cancer metastasis

June 7, 2016
Researchers have built a model to investigate the metastasis of cancer by examining the metabolism of breast epithelial cells and look at the role of signaling. This research, published in PLOS Computational Biology, may ...

New biomarker highly promising for predicting breast cancer outcomes

August 25, 2014
A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research published ahead of print in the journal Molecular and Cellular Biology.

Recommended for you

Breast cancer fuelled by mysterious Yin Yang protein

July 23, 2018
Scientists have unveiled clues about a mysterious molecule called Yin Yang1—and revealed it may fuel tumour growth in breast cancer.

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.